Safety, Tolerability, and EEG-Based Target Engagement of STP1 (PDE3,4 Inhibitor and NKCC1 Antagonist) in a Randomized Clinical Trial in a Subgroup of Patients with ASD
Erickson, Craig A, Perez-Cano, Laura, Pedapati, Ernest V, Painbeni, Eric, Bonfils, Gregory, Schmitt, Lauren M, Sachs, Hannah, Nelson, Meredith, De Stefano, Lisa, Westerkamp, Grace, de Souza, Adriano L S, Pohl, Oliver, Laufer, Offir, Issachar, Gil, Blaettler, Thomas, Hyvelin, Jean-Marc, Durham, Lynn A
Published in Biomedicines (27.06.2024)
Published in Biomedicines (27.06.2024)
Get full text
Journal Article